Zhou, W.; Wang, P.; Ti, X.; Yin, Y.; Huang, S.; Yang, Z.; Li, J.; Chai, G.; Lyu, B.; Li, Z.;
et al. Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis. Cancers 2022, 14, 3920.
https://doi.org/10.3390/cancers14163920
AMA Style
Zhou W, Wang P, Ti X, Yin Y, Huang S, Yang Z, Li J, Chai G, Lyu B, Li Z,
et al. Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis. Cancers. 2022; 14(16):3920.
https://doi.org/10.3390/cancers14163920
Chicago/Turabian Style
Zhou, Wei, Pang Wang, Xinyu Ti, Yutian Yin, Shigao Huang, Zhi Yang, Jie Li, Guangjin Chai, Bo Lyu, Zhaohui Li,
and et al. 2022. "Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis" Cancers 14, no. 16: 3920.
https://doi.org/10.3390/cancers14163920
APA Style
Zhou, W., Wang, P., Ti, X., Yin, Y., Huang, S., Yang, Z., Li, J., Chai, G., Lyu, B., Li, Z., Zhou, Y., Xiao, F., Xu, L., Shi, M., & Zhao, L.
(2022). Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis. Cancers, 14(16), 3920.
https://doi.org/10.3390/cancers14163920
